By week 76, 56% of those on belimumab were considered responders.

在76周是，56%的贝利单抗治疗组具有反应。

youdao

By week 76, 56% of those on belimumab were considered responders.

在76周是，56%的贝利单抗治疗组具有反应。

youdao